Frequent Arterial Emboli in a Patient with Acute Pulmonary Thromboembolism and Patent Foramen Ovale

2018 ◽  
Vol 53 ◽  
pp. 274.e7-274.e10
Author(s):  
Abdollah Amirfarhangi ◽  
Sam Zeraatian ◽  
Morteza Hassanzadeh
Cases Journal ◽  
2009 ◽  
Vol 2 (1) ◽  
pp. 8358 ◽  
Author(s):  
Giorgio Caretta ◽  
Debora Robba ◽  
Ivano Bonadei ◽  
Melissa Teli ◽  
Benedetta Fontanella ◽  
...  

2012 ◽  
Vol 159 (2) ◽  
pp. e29-e31 ◽  
Author(s):  
Yeonjeong Park ◽  
Hanul Choi ◽  
Seung Hyun Kim ◽  
Jinmo Kang ◽  
Woong Chol Kang ◽  
...  

2019 ◽  
Vol 18 (4) ◽  
pp. 258-259
Author(s):  
Rajesh Vijayvergiya ◽  
Kewal Kanabar ◽  
Sudhanshu Budakoty ◽  
Vivek Guleria ◽  
Navjyot Kaur ◽  
...  

2015 ◽  
Vol 114 (09) ◽  
pp. 614-622 ◽  
Author(s):  
Young Dae Kim ◽  
Dongbeom Song ◽  
Hyo Suk Nam ◽  
Kijeong Lee ◽  
Joonsang Yoo ◽  
...  

SummaryPatent foramen ovale (PFO) is a potential cause of cryptogenic stroke, given the possibility of paradoxical embolism from venous to systemic circulation. D-dimer level is used to screen venous thrombosis. We investigated the risk of embolism and mortality according to the presence of PFO and D-dimer levels in cryptogenic stroke patients. A total of 570 first-ever cryptogenic stroke patients who underwent transesophageal echocardiography were included in this study. D-dimer was assessed using latex agglutination assay during admission. The association of long-term outcomes with the presence of PFO and D-dimer levels was investigated. PFO was detected in 241 patients (42.3 %). During a mean 34.0 ± 22.8 months of follow-up, all-cause death occurred in 58 (10.2 %) patients, ischaemic stroke in 33 (5.8 %), and pulmonary thromboembolism in 6 (1.1 %). Multivariate Cox regression analysis showed that a D-dimer level of > 1,000 ng/ml was an independent predictor for recurrent ischaemic stroke in patients with PFO (hazard ratio 5.341, 95 % confidence interval 1.648–17.309, p=0.005), but not in those without PFO. However, in patients without PFO, a D-dimer level of > 1,000 ng/ml was independently related with all-cause mortality. The risk of pulmonary thromboembolism tended to be high in patients with high D-dimer levels, regardless of PFO. Elevated D-dimer levels in cryptogenic stroke were predictive of the long-term outcome, which differed according to the presence of PFO. The coexistence of PFO and a high D-dimer level increased the risk of recurrent ischaemic stroke. The D-dimer test in cryptogenic stroke patients may be useful for predicting outcomes and deciding treatment strategy.


Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4718-4718
Author(s):  
Sarah Thomas ◽  
Diana Braswell ◽  
Corinne Stephenson

Abstract Invasive surgery brings with it a unique set of post-surgical risks that are directly dependent on various factors including the specific surgical approach used, pre-existing comorbidities and features such as gender and age. Pulmonary thromboembolism is one of the most feared complications following surgery, and diagnosis and treatment of this entity is a challenging task for the clinician. Here we describe a case of massive pulmonary thromboembolism and associated coronary artery thromboemboli status post spinal fusion surgery in a 68 year-old man with an undetected patent foramen ovale (PFO). Although the decedent was managed clinically with proper deep venous thrombosis prophylaxis protocols and physical rehabilitation, he went into cardiorespiratory arrest after experiencing acute oxygen desaturation and newly detected right bundle branch block. PFO can be incidentally found in 25% of the adult population. Several clinical syndromes including stroke, migraine headaches and obstructive sleep apnea have been associated in patients with PFO, the last two from which the decedent suffered. The pathology of this unique case of massive pulmonary thromboembolism resulting in coronary artery thromboemboli in the setting of an undetected PFO is discussed. The discovery of PFO in patients prior to surgery, if detected early, may improve post-surgical outcomes. Figure 1. Massive pulmonary artery thromboembolism in situ, gross examination. Figure 1. Massive pulmonary artery thromboembolism in situ, gross examination. Figure 2. Histology, hematoxylin and eosin. A. Pulmonary thromboembolus at the bifurcation of the pulmonary arteries and pulmonary trunk. B. Hemorrhagic infarct and thromboemboli in varying stages of organization, right lower lobe, lung. C. Cross section of the proximal left anterior descending coronary artery with thromboembolus. D. Cross section of the posterior descending coronary artery with thromboembolus. Figure 2. Histology, hematoxylin and eosin. A. Pulmonary thromboembolus at the bifurcation of the pulmonary arteries and pulmonary trunk. B. Hemorrhagic infarct and thromboemboli in varying stages of organization, right lower lobe, lung. C. Cross section of the proximal left anterior descending coronary artery with thromboembolus. D. Cross section of the posterior descending coronary artery with thromboembolus. Figure 3. Patent foramen ovale, gross examination. Figure 3. Patent foramen ovale, gross examination. Disclosures No relevant conflicts of interest to declare.


2008 ◽  
Vol 63 (11) ◽  
pp. 1280-1284 ◽  
Author(s):  
E.T.D. Hoey ◽  
H. Mansoubi ◽  
D. Gopalan ◽  
C.K. Choong ◽  
A.D. Tasker

2000 ◽  
Vol 26 (9) ◽  
pp. 1400-1400 ◽  
Author(s):  
Dirk-Jan Slebos ◽  
Jaap E. Tulleken ◽  
Jack J. M. Ligtenberg ◽  
Jan G. Zijlstra ◽  
Tjip S. van der Werf

Sign in / Sign up

Export Citation Format

Share Document